Hepatic Safety and Antiretroviral Effectiveness in HIV-Infected Patients Receiving Naltrexone

Hepatic Complications of Obesity

(2010) Anna Mae Diehl   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Improving Clinical Outcomes in Treating Heroin Dependence

(2009) Gary K. Hulse et al.   ARCHIVES OF GENERAL PSYCHIATRY

Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications

(2009) Elisa Fabbrini et al.   HEPATOLOGY

Targeted Naltrexone for Problem Drinkers

(2009) Henry R. Kranzler et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Hepatic Safety of Once-Monthly Injectable Extended-Release Naltrexone Administered to Actively Drinking Alcoholics

(2008) Michael R. Lucey et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Naltrexone for the Management of Alcohol Dependence

(2008) Raymond F. Anton   NEW ENGLAND JOURNAL OF MEDICINE

Nonalcoholic Fatty Liver Disease: Hepatic Manifestation of Obesity and the Metabolic Syndrome

(2008) Hima Boppidi   POSTGRADUATE MEDICINE